2022年11月12日 · There are a few newer types of treatment that you can use for certain types of asthma. If you use an inhaler and still have problems with your asthma, biologic therapy targets different parts...

2024年2月27日 · New treatments for severe asthma may include biologics, surgical techniques, and leukotriene modifiers, among others. Researchers are still searching for new drugs to prevent and relieve...

2024年11月28日 · Researchers say they have found the first new treatment for asthma attacks in 50 years. The injection dampens part of the immune system that can go into overdrive in flare-ups of both...

Asthma treatment is taking another step forward. A new medication supports treating asthma symptoms and inflamed airways at the same time. The new treatment option is AIRSUPRA®. The medication involves one inhaler device. It combines: Albuterol, a short-acting beta-agonist (SABA) Budesonide, an inhaled corticosteroid

2023年1月11日 · FDA has approved Airsupra (albuterol and budesonide) inhalation aerosol for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of asthma attacks in...

2024年6月28日 · The GINA 2024 asthma update includes new guidance on medications, monitoring, treatment goals, remission, cough variant asthma, children, and more.

2022年5月15日 · A new formulation of albuterol and budesonide 24,25 in a single pressurized metered-dose inhaler was developed as albuterol–inhaled glucocorticoid rescue therapy for the control...

2021年12月17日 · Tezspire is a first-in-class biologic for severe asthma that acts at the top of the inflammatory cascade by targeting thymic stromal lymphopoietin (TSLP), an epithelial cytokine. 3 It is the first and only biologic to consistently and significantly reduce asthma exacerbations across Phase 2 and 3 clinical trials, which included a broad ...

2024年1月22日 · AstraZeneca announces AIRSUPRA ® (albuterol/budesonide), is now commercially available in the US by prescription. AIRSUPRA received FDA approval in January 2023 for the as-needed treatment or prevention of symptoms of asthma and to help prevent sudden severe breathing problems (asthma attacks) in people aged 18 years and older. 1.

2023年12月28日 · The SHAMAL study has made a significant breakthrough in severe asthma treatment. It demonstrates that the biologic therapy benralizumab enables patients to significantly reduce or stop the use of high-dose inhaled steroids, which are known for serious side effects.